Intervention safety
ADVERSE EVENTS
CB infusion in DukeACT was safe, with similar rates of mild and moderate adverse events in the intervention and placebo arms (CB: 4.2% mild, 5.0% moderate; Placebo: 6.6% mild, 4.9% moderate) [